1.76
3.30%
-0.06
After Hours:
1.82
0.06
+3.41%
Cerus Corp stock is traded at $1.76, with a volume of 1.13M.
It is down -3.30% in the last 24 hours and up +5.39% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.82
Open:
$1.79
24h Volume:
1.13M
Relative Volume:
0.81
Market Cap:
$326.86M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-6.069
EPS:
-0.29
Net Cash Flow:
$-47.77M
1W Performance:
+4.76%
1M Performance:
+5.39%
6M Performance:
-4.35%
1Y Performance:
+6.67%
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.76 | 326.86M | 156.37M | -37.49M | -47.77M | -0.29 |
ABT
Abbott Laboratories
|
117.96 | 203.52B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
389.71 | 148.24B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.21 | 132.25B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
85.68 | 109.12B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
71.55 | 42.07B | 6.60B | 4.16B | 490.10M | 2.34 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-12-24 | Initiated | Craig Hallum | Buy |
Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Oct-08-20 | Resumed | BTIG Research | Buy |
Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
Feb-26-20 | Initiated | BTIG Research | Buy |
Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
Aug-28-19 | Initiated | Stifel | Buy |
Aug-23-19 | Resumed | Stephens | Overweight |
Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
Dec-08-17 | Resumed | BTIG Research | Neutral |
Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
May-02-14 | Reiterated | MLV & Co | Buy |
Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
Mar-15-13 | Reiterated | MLV & Co | Buy |
Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
Nov-10-11 | Reiterated | MLV & Co | Buy |
Jun-03-11 | Initiated | Wedbush | Outperform |
Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Principal Financial Group Inc. Cuts Stock Holdings in Cerus Co. (NASDAQ:CERS) - Defense World
Reviewing enVVeno Medical (NASDAQ:NVNO) and Cerus (NASDAQ:CERS) - Defense World
Harvest Declares Big Pharma Split Corp. November 2024 Distribution - Business Wire
BayCom Corp Increases Quarterly Cash Dividend 50% to $0.15 Per Share - Business Wire
Sumitomo Mitsui Trust Group Inc. Has $12.25 Million Stake in Cerus Co. (NASDAQ:CERS) - MarketBeat
Short Interest in Cerus Co. (NASDAQ:CERS) Rises By 7.9% - MarketBeat
ZETA Investors Have Opportunity to Join Zeta Global Holdings Corp. Fraud Investigation with the Schall Law Firm - Business Wire
Cerus to Present at Stifel Healthcare Conference, Join Craig-Hallum Alpha Select Event | CERS Stock News - StockTitan
GSA Capital Partners LLP Has $1.67 Million Stock Holdings in Cerus Co. (NASDAQ:CERS) - MarketBeat
Cerus Corporation to Participate in Upcoming Investor Conferences - Yahoo Finance
Catherine Wood's Strategic Acquisition in Cerus Corp - GuruFocus.com
ARK Investment Management LLC Sells 1,675,153 Shares of Cerus Co. (NASDAQ:CERS) - MarketBeat
Viad Corp Announces Participation in Upcoming Conferences - Business Wire
OMI: 3 High-Potential Small-Cap Stocks Wall Street Loves - StockNews.com
Cerus Corporation (NASDAQ:CERS) Q3 2024 Earnings Call Transcript - Insider Monkey
Cerus Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Earnings call: Cerus Corporation posts robust Q3 revenue growth - Investing.com
Cerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Cerus: Q3 Earnings Snapshot - mySA
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Cerus Corporation Announces Third Quarter 2024 Financial Results - StockTitan
Cerus's Earnings: A Preview - Benzinga
Cerus Corp (CERS) Q3 2024 Earnings Report Preview: What To Expec - GuruFocus.com
Cathie Wood's ARK buys CERUS stock, sells MODERNA By Investing.com - Investing.com UK
Cathie Wood's ARK buys CERUS stock, sells MODERNA - Investing.com India
Cerus (CERS) to Release Quarterly Earnings on Wednesday - MarketBeat
Boise Cascade Company Third Quarter 2024 Earnings Webcast and Conference Call - Business Wire
Cathie Wood's ARK adds Amazon and BWX Technologies, cuts Oklo - Investing.com
Cerus (NASDAQ:CERS) Given New $3.00 Price Target at Stifel Nicolaus - Defense World
Cerus Co. (NASDAQ:CERS) Shares Purchased by The Manufacturers Life Insurance Company - Defense World
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting - StockTitan
Cerus price target lowered to $3 from $6 at Stifel - Yahoo Finance
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024 - StockTitan
Stifel cuts Cerus stock target on EU review setback - Investing.com
Cerus (NASDAQ:CERS) PT Lowered to $3.00 at Stifel Nicolaus - MarketBeat
Cerus stock price target unchanged as TD Cowen cites evolving EU strategy and increased BARDA funding - Investing.com
Stifel cuts Cerus stock target, maintains Buy rating - Investing.com
Cerus secures $248 million BARDA contract for RBC system - Investing.com
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe - Business Wire
An analyst sees good growth prospects for Cerus Corp. (CERS) - SETE News
Cerus Corp. [CERS] Green Kevin Dennis sells 54,272 Shares for $0.12 million - Knox Daily
A stock that deserves closer examination: Cerus Corp. (CERS) - US Post News
Cerus Corp. [CERS] Shares Jump Approximately 22.26% Over the Year - Knox Daily
Cerus Corp (CERS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive EBITDA By GuruFocus - Investing.com Canada
Cerus Corp (CERS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive EBITDA - Yahoo Finance
Was Cerus Corp. (CERS)’s session last reading good? - US Post News
Closing Bell Recap: Cerus Corp. (CERS) Ends at 1.72, Reflecting a 1.18 Upturn - The Dwinnex
Monitoring Cerus Corp. (CERS) after recent insider movements - Knox Daily
Cerus Corp.: Navigating Market Fluctuations with a 315.94M Market Cap - The InvestChronicle
Is Cerus Corp. (CERS) positioned for future growth? - SETE News
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):